Work

Gefitinib versus Docetaxel bei Patienten mit einem fortgeschrittenen oder metastasiertem nichtkleinzelligen Lungenkarzinom (NSCLC) nach platinbasierter Vortherapie: Ergebnisse einer randomisierten Phase III Studie (INTEREST)

Year: 2008

Type: article

Study design: Clinical Trial

Source: Pneumologie

DOI: 10.1055/s-2008-1074240

Authors: M Reck, E Kim, R Gervais, V Hirsh, T Mok, M Socinski, Y Wu, L Li, C Watkins, E Lowe, J Douillard

Institutions: LungenClinic Grosshansdorf, The University of Texas MD Anderson Cancer Center, Centre François Baclesse, McGill University Health Centre, Chinese University of Hong Kong, Prince of Wales Hospital, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Guangdong Provincial People's Hospital, Peking Union Medical College Hospital, AstraZeneca (United Kingdom), AstraZeneca (United States)

Language: German

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2077828969

FWCI:

Cites:

Cited by:

Related to: 10